光合生物 (873591.OC)

+ 收藏

现金流量表(光合生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 34,925,178.4772,926,231.8437,439,772.2779,538,273.5245,168,955.82
 收到的税费返还(元) ---372,834.80-
 收到其他与经营活动有关的现金(元) 56,305.14813,152.37597,762.67589,396.3145,237.34
 经营活动现金流入小计(元) 34,981,483.6173,739,384.2138,037,534.9480,500,504.6345,214,193.16
 购买商品、接受劳务支付的现金(元) 26,736,550.8853,560,441.4627,160,872.6369,179,415.8840,151,886.19
 支付给职工以及为职工支付的现金(元) 5,447,794.437,715,929.495,043,671.297,280,776.484,641,346.72
 支付的各项税费(元) 2,672,446.784,099,207.412,727,992.242,484,906.90642,291.88
 支付其他与经营活动有关的现金(元) 662,169.681,746,561.48864,935.182,107,447.83932,676.41
 经营活动现金流出小计(元) 35,518,961.7767,122,139.8435,797,471.3481,052,547.0946,368,201.20
 经营活动产生的现金流量净额(元) -537,478.166,617,244.372,240,063.60-552,042.46-1,154,008.04
二、投资活动产生的现金流量
 收回投资收到的现金(元) 14,000,000.0027,000,000.004,000,000.0048,100,000.0027,000,000.00
 取得投资收益收到的现金(元) 75,466.03169,515.702,893.15282,194.33196,145.37
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -3,989,000.00---
 投资活动现金流入小计(元) 14,075,466.0331,158,515.704,002,893.1548,382,194.3327,196,145.37
 购建固定资产、无形资产和其他长期资产支付的现金(元) 665,000.00596,600.00314,600.0082,300.0069,800.00
 投资支付的现金(元) 8,700,000.0040,000,000.0010,500,000.0039,600,000.0018,500,000.00
 投资活动现金流出小计(元) 9,365,000.0040,596,600.0010,814,600.0039,682,300.0018,569,800.00
 投资活动产生的现金流量净额(元) 4,710,466.03-9,438,084.30-6,811,706.858,699,894.338,626,345.37
三、筹资活动产生的现金流量
 分配股利、利润或偿付利息支付的现金(元) 5,751,700.002,239,600.002,239,600.002,748,600.00-
 筹资活动现金流出小计(元) 5,751,700.002,239,600.002,239,600.002,748,600.00-
 筹资活动产生的现金流量净额(元) -5,751,700.00-2,239,600.00-2,239,600.00-2,748,600.00-
四、汇率变动对现金及现金等价物的影响(元) -1,870.7834,721.063,470.6258,294.9945,751.61
五、现金及现金等价物净增加额(元) -1,580,582.91-5,025,718.87-6,807,772.635,457,546.867,518,088.94
 加:期初现金及现金等价物余额(元) 4,003,557.429,029,276.299,029,276.293,571,729.433,571,729.43
 期末现金及现金等价物余额(元) 2,422,974.514,003,557.422,221,503.669,029,276.2911,089,818.37
补充资料:
 净利润(元) 1,500,021.286,131,626.491,400,498.082,557,650.271,101,041.04
 固定资产和投资性房地产折旧(元) 327,612.72648,482.01324,422.88632,121.17313,139.65
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 327,612.72648,482.01324,422.88632,121.17313,139.65
 无形资产摊销(元) 33,477.4869,734.9735,330.8270,661.6435,330.82
 处置固定资产、无形资产和其他长期资产的损失(元) --3,376,079.17---
 投资损失(元) -75,466.03-169,515.70-2,893.15-282,194.33-196,145.37
 递延所得税(元) 31,979.44-50,461.21-7,150.9620,095.1522,588.69
  其中:递延所得税资产减少(元) 31,979.44-50,461.21-7,150.9620,095.1522,588.69
 存货的减少(元) -1,617,336.625,688,158.624,356,527.66-5,381,699.31-1,081,329.70
 经营性应收项目的减少(元) 5,049,254.81-4,841,247.10-2,695,313.348,057,128.025,923,783.38
 经营性应付项目的增加(元) -5,573,824.952,320,989.31-1,314,377.45-5,823,902.09-6,982,049.87
 现金的期末余额(元) 2,422,974.514,003,557.422,221,503.669,029,276.2911,089,818.37
 减:现金的期初余额(元) 4,003,557.429,029,276.299,029,276.293,571,729.433,571,729.43
 现金及现金等价物的净增加额(元) -1,580,582.91-5,025,718.87-6,807,772.635,457,546.867,518,088.94
公告日期 2024-08-232024-04-262023-08-212023-04-262022-08-22
审计意见(境内) 带强调事项段的无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院